首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >P38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication
【24h】

P38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication

机译:DNA损伤后P38 MAPK / MK2介导的miR-34c诱导阻止Myc依赖性DNA复制

获取原文
获取原文并翻译 | 示例
           

摘要

The DNA damage response activates several pathways that stall the cell cycle and allow DNA repair. These consist of the well-characterized ATR (Ataxia telangiectasia and Rad-3 related)/ CHK1 and ATM (Ataxia telangiectasia mutated)/CHK2 pathways in addition to a newly identified ATM/ATR/p38MAPK/MK2 checkpoint. Crucial to maintaining the integrity of the genome is the S-phase checkpoint that functions to prevent DNA replication until damaged DNA is repaired. Inappropriate expression of the pro-to-oncogene c-Myc is known to cause DNA damage. One mechanism by which c-Myc induces DNA damage is through binding directly to components of the prereplicative complex thereby promoting DNA synthesis, resulting in replication-associated DNA damage and checkpoint activation due to inappropriate origin firing. Here we show that following etoposide-induced DNA damage translation of c-Myc is repressed by miR-34c via a highly conserved target-site within the 3' UTR. While miR-34c is induced by p53 following DNA damage, we show that in cells lacking p53 this is achieved by an alternative pathway which involves p38 MAPK signalling to MK2. The data presented here suggest that a major physiological target of miR-34c is c-Myc. Inhibition of miR-34c activity prevents S-phase arrest in response to DNA damage leading to increased DNA synthesis, DNA damage, and checkpoint activation in addition to that induced by etoposide alone, which are all reversed by subsequent c-Myc depletion. These data demonstrate that miR-34c is a critical regulator of the c-Myc expression following DNA damage acting downstream of p38 MAPK/MK2 and suggest that miR-34c serves to remove c-Myc to prevent inappropriate replication which may otherwise lead to genomic instability.
机译:DNA损伤反应激活了几个阻止细胞周期并允许DNA修复的途径。除了新确定的ATM / ATR / p38MAPK / MK2检查点外,这些还包括特征明确的ATR(共济失调毛细血管扩张症和Rad-3相关)/ CHK1和ATM(共济失调毛细血管扩张突变)/ CHK2途径。 S期检查点是维持基因组完整性的关键,其作用是防止DNA复制,直到修复受损的DNA。原癌基因c-Myc的不适当表达引起DNA损伤。 c-Myc诱导DNA损伤的一种机制是通过直接与复制前复合物的成分结合,从而促进DNA合成,由于不适当的来源激发而导致复制相关的DNA损伤和检查点激活。在这里,我们显示了依托泊苷诱导的DNA损伤后,miR-34c通过3'UTR中高度保守的靶位点抑制了c-Myc的翻译。虽然miR-34c是由DNA损伤后的p53诱导的,但我们表明在缺乏p53的细胞中,这是通过涉及p38 MAPK信号传导至MK2的替代途径实现的。此处提供的数据表明,miR-34c的主要生理目标是c-Myc。抑制miR-34c活性可防止S期停滞,响应DNA损伤,从而导致DNA合成,DNA损伤和检查点活化,而单独由依托泊苷诱导的活化则被随后的c-Myc耗尽所逆转。这些数据表明,在DNA损伤作用于p38 MAPK / MK2下游后,miR-34c是c-Myc表达的关键调节子,并表明miR-34c可去除c-Myc以防止不适当的复制,否则可能导致基因组不稳定。

著录项

  • 来源
  • 作者单位

    Center for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Molecular and Metabolic Signalling, Division of Basic Medical Sciences, St. George's, University of London, Cranmer Terrace, London, 5W17 0RE, UK;

    rnTheodor-Boveri-Institute, Biocenter, Am Hubland, Wuerzburg, D-97074, Germany;

    rnDepartment of Biochemistry, University of Leicester, Lancaster Road, Leicester, LE1 9HN, UK;

    rnDepartment of Chemistry and Biochemistry, School of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnHannover Medical School, Institute of Biochemistry, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany;

    rnTheodor-Boveri-Institute, Biocenter, Am Hubland, Wuerzburg, D-97074, Germany;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

    rnCenter for Biomolecular Sciences, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, UK;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    c-myc; microRNA; translation; cancer; cell-cycle;

    机译:c-myc;微小RNA;翻译;癌症;细胞周期;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号